Skip to main content
Fig. 5 | BMC Biotechnology

Fig. 5

From: Novel fusion proteins for the antigen-specific staining and elimination of B cell receptor-positive cell populations demonstrated by a tetanus toxoid fragment C (TTC) model antigen

Fig. 5

Cytotoxic activity of recombinant TTC-ETA’ on hybridoma cells. The hybridoma cell lines 5E4 (; n = 4) and 8.18-C5 (■; n = 3) were incubated with serial dilutions of TTC-ETA’ (a) and TTC (b) in complete RPMI 1640 cell culture medium. After incubation at 37 °C and 5 % CO2 for 72 h, the cells were refreshed with 50 μl RPMI 1640 medium containing XTT/phenazine methosulfate and incubated for another 4 h. Absorbance was measured at 450 nm and 630 nm on an ELISA reader. The half maximal inhibitory protein concentration (EC50) relative to untreated control cells was calculated using GraphPad Prism software. The recombinant TTC-ETA’ exhibits a dose-dependent cytotoxicity on the target hybridoma cell line 5E4 with an EC50of 1.3 nM ± 0.4 nM but has no effect on the control cell line 8.18-C5. These data represent the mean ± SD of three independent experiments performed in triplicates. *, P < 0.05; ** , P < 0.01; P < 0.001 versus control cells

Back to article page